RenovoRx (RNXT) Times Interest Earned (2020 - 2026)
RenovoRx (RNXT) posted Times Interest Earned of -$266.85 for Q1 2026, up 99.33% sequentially from -$40022.7 in Q4 2025, and down 2602.78% YoY from $10.66 in Q1 2025.
RenovoRx (RNXT) Times Interest Earned (2020 - 2026) Analysis & Trends
RenovoRx has reported Times Interest Earned for 7 years, with the latest figure at -$266.85 in Q1 2026.
- Quarterly Times Interest Earned fell 2602.78% year-over-year to -$266.85 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$989.92 (down 2587.23% YoY) and the FY2025 annual result came in at -$0.63, up 3.33% from the prior year.
- Times Interest Earned rose to -$266.85 in Q1 2026 per RNXT's latest filing, from -$40022.7 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.16 in Q4 2024 and troughed at -$40022.7 in Q4 2025.
- A 5-year average of -$2374.3 and a median of -$3.72 in 2025 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned jumped 91.63% in 2024, then sank 25521991.74% in 2025.
- Over 5 years, Times Interest Earned stood at -$2.34 in 2022, then gained by 19.84% to -$1.87 in 2023, then surged by 91.63% to -$0.16 in 2024, then tumbled by 25521991.74% to -$40022.7 in 2025, then soared by 99.33% to -$266.85 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$266.85, -$40022.7, and -$3.72 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.92 Bn | 53.78 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.99 Bn | 9.60 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 1.42 |
| 10 | RenovoRx | 61.49 Mn | 61.49 Mn | 766,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.88 |
| Mar 31, 2026 | -266.85 |
| Dec 31, 2025 | -40,022.73 |
| Sep 30, 2025 | -3.72 |
| Jun 30, 2025 | -2.71 |
| Mar 31, 2025 | -9.87 |
| Dec 31, 2024 | -0.16 |
| Sep 30, 2024 | -14.50 |
| Jun 30, 2024 | -10.46 |
| Mar 31, 2024 | -4.53 |
| Dec 31, 2023 | -1.87 |
| Sep 30, 2023 | -8.62 |
| Jun 30, 2023 | -3.97 |
| Mar 31, 2023 | -1.53 |
| Dec 31, 2022 | -2.34 |
| Sep 30, 2022 | -3.01 |
| Jun 30, 2022 | -3.68 |
| Mar 31, 2022 | -2.30 |
| Dec 31, 2021 | 3.21 |
| Sep 30, 2021 | -0.37 |